Our 2-day event will take place in 2024 in Pennsylvania, a thriving hub of innovation. We are aiming to bring 1500 global executives, 300 speakers and 50 start-ups.
The agenda covers everything from the use and management of multiomic data to the development of personalised therapies as well as covering the actual generation of the data.
BioTechX Tracks
AI IN DRUG DISCOVERY AND DEVELOPMENT
Advances in AI for drug development
AI in clinical trials
Limitations of AI in drug development
Data expansion in AI
LLMs
Applications of LLMs in Drug Development
Clinical Research
Practical application of LLMs
Cost effective ways to enable AI
Language models in Pharma
PRECISION MEDICINE AND LIQUID BIOPSY
Manufacturing CAR T cells
Immuno-oncology
Multi-cancer early detection
Personalised medicine for drug safety
BIG DATA IN ONCOLOGY
Clinical biomarkers
Tumour microenvironment
Translational data sources
Analytical and regulatory challenges
Oncology drug development
DATA MANAGEMENT, STORAGE AND ARCHITECHTURE
Data platforms
FAIR architectures
Enterprise data
Electronic lab notebook
ANALYTICS PLATFORM
Data privacy
AI/ML driving clinical outcomes
Industrialising AI
Analytics paradigm
DATA INTEGRATION + FAIR
Research and development
Language models
Silo busting
Pre and post acquisition
BIOINFORMATICS + INSILICO R&D
Clinical development
Data driven drug discovery
Global biologics informatics platforms
Multi omics
DIGITAL TRANSFORMATION
Digital health solutions
Applications in the life science industry
Drug development efficiency
Inclusive data management
REAL WORLD EVIDENCE
Real world data
Future applications
Leveraging AI for RWE
Real world evidence in the clinical setting
GENE THERAPY
Treating genetic disorders with therapy
CRISPR and gene editing
Ethical concerns and regulations
BIOMARKERS + COMPANION DIAGNOSTICS
Image based machine learning models
Single molecule detection
Digital biomarkers
Multi-cancer early detection
RARE DISEASE IN GENOMICS
In-vivo gene editing
Accelerating medicines for rare diseases
Neurodevelopmental disorders
Future of rare diseases
QUANTUM INTEGRATION
Quantum machine learning
Quantum research
Drug discovery and development
We met very relevant people and saw excellent and inspiring presentations
VP Dimensions Industrial Solutions - Digital Science
Get involved at BioTechX USA
TO SPONSOR
Myra Christodoulou
myra.christodoulou@terrapinn.com
Joshua Kennedy
joshua.kennedy@terrapinn.com
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events